Seattle biotech firm Shape Therapeutics inks gene therapy deal

Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s

Investors bet on AI start-ups to turbocharge drug development

Articles by Charlotte Schubert – GeekWire – Page 16 of 18

White House cybersecurity summit to include 's Andy Jassy, Microsoft's Satya Nadella – GeekWire

Coriolis Pharma Contract Pharma

The top biotech hubs in 2022

Suicide gene therapy in cancer and HIV-1 infection: An alternative

The History of Drug Discovery and Development in Seattle

Seattle biotech firm Shape Therapeutics inks gene therapy deal

At $3m, Bluebird Bio's new gene therapy is the most expensive drug